Fangsheng Pharmaceutical\'s dividend management system (reviewed and approved by the 2nd Extraordinary General Meeting of Shareholders in 2024)

SZSI · Sep 28

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.